Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression
about
Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRASImpact of somatic mutations on patterns of metastasis in colorectal cancerImpaired coordination between signaling pathways is revealed in human colorectal cancer using single-cell mass cytometry of archival tissue blocksDNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancerCombined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth.Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patientsCell Pluripotency Levels Associated with Imprinted Genes in Human.Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Molecular biomarkers in colorectal carcinoma.The State of the Art in Colorectal Cancer Molecular Biomarker Testing.The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations.Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer.Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.The mystery of oncogenic KRAS: Lessons from studying its wild-type counter part.Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas.EGFR signalling and oncogenic pathway signature in colorectal cancer.Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study.
P2860
Q26766535-93F24393-E030-4047-92D9-730CB06E2216Q26772279-FE46EF2A-2F88-4541-92E7-F871DC36BB19Q30358990-612C59A7-F1C7-4C4E-BB29-5D6DE8754598Q33679684-0F53AD83-A599-4A5E-88AF-9D4CDCCCC233Q33685977-F897903E-7C55-4A35-B622-471F006264E8Q33757027-ADB142DC-000B-4544-B004-5E0592BC5BBBQ33861210-3CAAA83C-CD1C-4800-8A9F-DF2C75053C01Q36173051-5D708BBC-5DB5-4E4F-831B-CAA36F1F06B8Q37666240-FBA1CB22-8E2B-4BF7-BD06-12979E3DFB19Q38555225-1F3EF303-C8C8-4569-A70C-3689F8F7C374Q38559669-F23DF45E-3AA4-4760-B8F5-D27E956FF217Q38724312-7F9E9A8B-D8E6-43BF-AD11-71DF0D929D6EQ38770200-DAEE7A65-039C-4922-AAF4-6212496F203DQ38933681-28FE8C91-F353-4B80-B34D-92C54CC32C6AQ40226443-A4F485F2-71DA-4D3C-B4DE-9AA7F4215E2DQ41867768-CB6CA75D-D8A4-47A6-AA28-FD12B5B6B386Q42316814-D9BC0473-310A-4DB8-B4AB-4481262DAC5EQ44995693-8ABD4E71-70B4-4B24-AA7A-98DE2B6265D1Q47128365-5D0F9938-B8DD-4B86-8981-298F8D0B80F7Q51732351-32CB3F34-C55E-40EE-9CCD-88957C9083E3Q52571294-EE122BAB-5C1E-4378-865D-4E8DCB62E74DQ54441407-E656BA24-AB0A-44B5-8AF8-8269E0122670Q54949200-9125B50B-A1A7-462A-82E5-240B9D86FA59
P2860
Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mutant N-RAS protects colorect ...... er development and progression
@ast
Mutant N-RAS protects colorect ...... er development and progression
@en
type
label
Mutant N-RAS protects colorect ...... er development and progression
@ast
Mutant N-RAS protects colorect ...... er development and progression
@en
prefLabel
Mutant N-RAS protects colorect ...... er development and progression
@ast
Mutant N-RAS protects colorect ...... er development and progression
@en
P2093
P2860
P1433
P1476
Mutant N-RAS protects colorect ...... er development and progression
@en
P2093
Adam J Bass
Channing J Der
David B Solit
Efsevia Vakiani
Gerald C Chu
James M Bugni
Jessica Gierut
Kevin M Haigis
Mark Philips
Shouyong Peng
P2860
P304
P356
10.1158/2159-8290.CD-12-0198
P50
P577
2012-12-28T00:00:00Z